Antibodies are proteins produced by B cells that recognize and help eliminate foreign objects like bacteria and viruses. Monoclonal antibodies target specific proteins on the membranes or in the cytosol of targeted cells. They find increasing application in targeted cancer therapies and autoimmune disease treatment. Monoclonal antibodies confer high specificity and minimal toxicity compared to conventional therapies. Promising clinical trial results for conditions like rheumatoid arthritis, Crohn's disease, psoriasis and various cancers have spurred their adoption.
Market key trends:
The growing popularity of targeted therapies is one of the key trends driving growth in the antibodies market. Monoclonal antibodies offer significant advantages over traditional chemotherapy by selectively targeting cancer cells while sparing healthy cells. This results in fewer side effects and improved clinical outcomes. Promising pipeline candidates for cancers like lung cancer, breast cancer and leukemia are garnering significant R&D investments from key players. For example, Bain Capital has invested $100 million in Harmony Biosciences’ pipeline drug for narcolepsy treatment. Such targeted funding is accelerating the development of novel antibodies to treat various diseases more effectively. This growing demand for safer and effective targeted therapies will continue driving market revenues upwards over the forecast period.
Segment Analysis
The global antibodies market is dominated by the monoclonal antibodies segment, which accounts for around 80% of the total market share. Monoclonal antibodies have seen increasing demand due to their high specificity and affinity towards antigen detection. They are also more efficacious and have fewer side effects than other antibody types.
Key Takeaways
Global Antibodies Market Size is expected to witness high growth over the forecast period of 2023 to 2030.
Regional analysis: The North America region currently dominates the global antibodies market and is expected to remain the highest revenue generating region during the forecast period. This can be attributed to the rising prevalence of chronic and infectious diseases, along with growing pharmaceutical R&D expenditure in the region.
Key players: Key players operating in the antibodies market are Bose Corporation, Beats Electronics, 3M, Audio-Technica Ltd, Panasonic Corporation, Apple Inc., Bowers & Wilkins Group Ltd., GN Group, Harman International, Inc., Sony Corporation, Logitech International S.A., Koninklijke Philips N.V., Pioneer Corporation, and Sennheiser Electronic GmbH & Co. KG.
Explore More Related Article On This Topic: https://www.pressreleasebulletin.com/antibodies-market-trends/
Explore More Related Article On This Topic: https://allmeaninginhindi.com/exploring-the-vital-world-of-intravenous-solutions-for-health-and-healing/
Comments
0 comment